Human gene
TNNT2 troponin T type 2 (cardiac)
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 162 | Cardiomyopathy, dilated | turkey | TNNT2 | one to one | Drug |
53.6
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| dilated cardiomyopathy 1A | MONDO:0007269 | 0.07 | 4 |
| arrhythmogenic right ventricular dysplasia 1 | MONDO:0007152 | 0.07 | 3 |
| dilated cardiomyopathy 2A | MONDO:0012746 | 0.05 | 1 |
| dilated cardiomyopathy 3B | MONDO:0010542 | 0.04 | 1 |
| Barth syndrome | MONDO:0010543 | 0.03 | 3 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Levosimendan | positive modulator | Approved |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.